The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
Open accessAbstract
Caveolin-1 is the principal structural protein of caveolae membranes in fibroblasts and endothelia. Recently, we have shown that the human CAV-1 gene is localized to a suspected tumor suppressor locus, and mutations in Cav-1 have been implicated in human cancer. Here, we created a caveolin-1 null (CAV-1 -/-) mouse model, using standard homologous recombination techniques, to assess the role of caveolin-1 in caveolae biogenesis, endocytosis, cell proliferation, and endothelial nitric-oxide synthase (eNOS) signaling. Surprisingly, Cav-1 null mice are viable. We show that these mice lack caveolin-1 protein expression and plasmalemmal caveolae. In addition, analysis of cultured fibroblasts from Cav-1 null embryos reveals the following: (i) a loss of caveolin-2 protein expression; (ii) defects in the endocytosis of a known caveolar ligand, i.e. fluorescein isothiocyanate-albumin; and (iii) a hyperproliferative phenotype. Importantly, these phenotypic changes are reversed by recombinant expression of the caveolin-1 cDNA. Furthermore, examination of the lung parenchyma (an endothelial-rich tissue) shows hypercellularity with thickened alveolar septa and an increase in the number of vascular endothelial growth factor receptor (Flk-1)-positive endothelial cells. As predicted, endothelial cells from Cav-1 null mice lack caveolae membranes. Finally, we examined eNOS signaling by measuring the physiological response of aortic rings to various stimuli. Our results indicate that eNOS activity is up-regulated in Cav-1 null animals, and this activity can be blunted by using a specific NOS inhibitor, nitro-l-arginine methyl ester. These findings are in accordance with previous in vitro studies showing that caveolin-1 is an endogenous inhibitor of eNOS. Thus, caveolin-1 expression is required to stabilize the caveolin-2 protein product, to mediate the caveolar endocytosis of specific ligands, to negatively regulate the proliferation of certain cell types, and to provide tonic inhibition of eNOS activity in endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA
Farquhar, M. G., & Palade, G. E. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.375 · Cited by 3,635
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,258
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution
Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,525
Okamoto, T., Schlegel, A., Scherer, P. E., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5419 · Cited by 1,498
Self-citationFero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Setting the Standards: Quality Control in the Secretory Pathway
Ellgaard, L., Molinari, M., & Helenius, A. (1999) · Science · doi:10.1126/science.286.5446.1882 · Cited by 1,192
Posttranslational Quality Control: Folding, Refolding, and Degrading Proteins
Wickner, S., Maurizi, M. R., & Gottesman, S. (1999) · Science · doi:10.1126/science.286.5446.1888 · Cited by 1,071
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Wu, H., Liu, X., Jaenisch, R., & Lodish, H. F. (1995) · Cell · doi:10.1016/0092-8674(95)90234-1 · Cited by 1,017
Song, K. S., Li, S., Okamoto, T., Quilliam, L. A., Sargiacomo, M., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9690 · Cited by 1,000
Self-citationSargiacomo, M., Sudol, M., Tang, Z., & Lisanti, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.4.789 · Cited by 953
Self-citationLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
Lisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y. H., Cook, R. F., & Sargiacomo, M. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.111 · Cited by 906
Self-citationVIP21/caveolin is a cholesterol-binding protein.
Murata, M., Peränen, J., Schreiner, R., Wieland, F., Kurzchalia, T. V., & Simons, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10339 · Cited by 899
Gerdes, J., Li, L., Schlueter, C. J., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E., & Flad, H. D. (1991) · PubMed · Cited by 889
Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin
Garcı́a-Cardeña, G., Martasek, P., Masters, B. S. S., Skidd, P. M., Couet, J., Li, S., Lisanti, M. P., & Sessa, W. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25437 · Cited by 821
Self-citationTHE FINE STRUCTURE OF THE GALL BLADDER EPITHELIUM OF THE MOUSE
Yamada, E. (1955) · The Journal of Cell Biology · doi:10.1083/jcb.1.5.445 · Cited by 812
Acylation Targets Endothelial Nitric-oxide Synthase to Plasmalemmal Caveolae
Shaul, P. W., Smart, E. J., Robinson, L. J., German, Z., Yuhanna, I. S., Ying, Y., Anderson, R. G. W., & Michel, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6518 · Cited by 800
Li, S., Couet, J., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29182 · Cited by 777
Self-citationSchlüter, C., Duchrow, M., Wohlenberg, C., Becker, M. H., Key, G., Flad, H. D., & Gerdes, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.3.513 · Cited by 765
Tang, Z., Scherer, P. E., Okamoto, T., Song, K., Chu, C., Kohtz, D. S., Nishimoto, I., Lodish, H. F., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2255 · Cited by 737
Self-citationExpression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells
Song, K. S., Scherer, P. E., Tang, Z., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D. S., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15160 · Cited by 700
Self-citationGarcía-Cardeña, G., Oh, P., Liu, J., Schnitzer, J. E., & Sessa, W. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6448 · Cited by 679
Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins
Couet, J., Sargiacomo, M., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30429 · Cited by 664
Self-citationDirect Interaction of Endothelial Nitric-oxide Synthase and Caveolin-1 Inhibits Synthase Activity
Ju, H., Zou, R., Venema, V. J., & Venema, R. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18522 · Cited by 640
Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis
Lisanti, M. P., Scherer, P. E., Tang, Z., & Sargiacomo, M. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90114-7 · Cited by 637
Self-citationReciprocal Regulation of Endothelial Nitric-oxide Synthase by Ca2+-Calmodulin and Caveolin
Michel, J. B., Feron, O., Sacks, D., & Michel, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15583 · Cited by 613
Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin
Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., & Lisanti, M. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15693 · Cited by 608
Self-citationMutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, M., Egeo, A., Donati, M. A., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-365 · Cited by 598
Self-citationDe novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.
Fra, A. M., Williamson, E., Simons, K., & Parton, R. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8655 · Cited by 596
A subset of p53-deficient embryos exhibit exencephaly
Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., & Jacks, T. (1995) · Nature Genetics · doi:10.1038/ng0695-175 · Cited by 580
Bucci, M., Gratton, J.-P., Rudic, R. D., Acevedo, L., Roviezzo, F., Cirino, G., & Sessa, W. C. (2000) · Nature Medicine · doi:10.1038/82176 · Cited by 572
Emerging Themes in Lipid Rafts and Caveolae
Galbiati, F., Razani, B., & Lisanti, M. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00472-x · Cited by 567
Self-citationIdentification, sequence, and expression of caveolin-2 defines a caveolin gene family.
Scherer, P. E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F., & Lisanti, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.131 · Cited by 561
Self-citationOligomeric structure of caveolin: implications for caveolae membrane organization.
Sargiacomo, M., Scherer, P. E., Tang, Z., Kübler, E., Song, K. S., Sanders, M. C., & Lisanti, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9407 · Cited by 548
Self-citationCell-type and Tissue-specific Expression of Caveolin-2
Scherer, P. E., Lewis, R. Y., Volonté, D., Engelman, J. A., Galbiati, F., Couet, J., Kohtz, D. S., van Donselaar, E., Peters, P., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29337 · Cited by 526
Self-citationA Role for Caveolin in Transport of Cholesterol from Endoplasmic Reticulum to Plasma Membrane
Smart, E. J., Ying, Y.-S., Donzell, W. C., & Anderson, R. G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29427 · Cited by 501
Reduction of caveolin and caveolae in oncogenically transformed cells.
Koleske, A. J., Baltimore, D., & Lisanti, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1381 · Cited by 499
Self-citationCholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
Thiele, C., Hannah, M. J., Fahrenholz, F., & Huttner, W. B. (2000) · Nature Cell Biology · doi:10.1038/71366 · Cited by 498
Monier, S., Parton, R. G., Vogel, F., Behlke, J., Henske, A., & Kurzchalia, T. V. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.7.911 · Cited by 479
Galbiati, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6633 · Cited by 471
Glenney, J. R., & Zokas, L. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2401 · Cited by 457
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
Newbold, R. F., & Overell, R. W. (1983) · Nature · doi:10.1038/304648a0 · Cited by 436
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B., & Schnitzer, J. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201661 · Cited by 421
Three human transforming genes are related to the viral ras oncogenes.
Shimizu, K., Goldfarb, M., Suard, Y., Perucho, M., Li, Y., Kamata, T., Feramisco, J., Stavnezer, E., Fogh, J., & Wigler, M. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2112 · Cited by 387
Furuchi, T., & Anderson, R. G. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21099 · Cited by 371
Engelman, J. A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D. S., & Lisanti, M. P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00470-0 · Cited by 371
Self-citationGlenney, J. R., & Soppet, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10517 · Cited by 370
Engelman, J. A., Wykoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16374 · Cited by 369
Self-citationGhitescu, L., Fixman, A., Simionescu, M., & Simionescu, N. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.4.1304 · Cited by 369
Mutation in the Mismatch Repair Gene Msh6 Causes Cancer Susceptibility
Edelmann, W., Yang, K., Umar, A., Heyer, J., Lau, K., Fan, K., Liedtke, W., Cohen, P. E., Kane, M. F., Lipford, J. R., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80433-x · Cited by 365
Self-citationTyrosine Phosphorylation of a 22-kDa Protein Is Correlated with Transformation by Rous Sarcoma Virus
Glenney, J. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47038-5 · Cited by 363
Scherer, P. E., Tang, Z., Chun, M., Sargiacomo, M., Lodish, H. F., & Lisanti, M. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16395 · Cited by 355
Self-citationRegulation of caveolin and caveolae by cholesterol in MDCK cells
Hailstones, D., Sleer, L. S., Parton, R. G., & Stanley, K. K. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33898-0 · Cited by 309
Herrera, R. E., Sah, V. P., Williams, B. O., Mäkelä, T. P., Weinberg, R. A., & Jacks, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2402 · Cited by 304
Bender, F. C., Reymond, M. A., Bron, C., & Quest, A. F. G. (2000) · PubMed · Cited by 278
Latres, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3496 · Cited by 257
Up-regulation of Caveolin Attenuates Epidermal Growth Factor Signaling in Senescent Cells
Park, W.-Y., Park, J.-S., Cho, K.-A., Kim, D.-I., Ko, Y.-G., Seo, J.-S., & Park, S. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908162199 · Cited by 229
Invasion activating caveolin-1 mutation in human scirrhous breast cancers.
Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y., Hayakawa, T., & Hamaguchi, M. (2001) · PubMed · Cited by 221
Expression and Characterization of Recombinant Caveolin
Li, S., Song, K. S., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.568 · Cited by 220
Self-citationMora, R., Bonilha, V. L., Marmorstein, A., Scherer, P. E., Brown, D., Lisanti, M. P., & Rodriguez-Boulan, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25708 · Cited by 216
Self-citationEngelman, J. A., Lee, R. J., Karnezis, A., Bearss, D. J., Webster, M., Siegel, P., Muller, W. J., Windle, J. J., Pestell, R. G., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20448 · Cited by 209
Self-citationMonier, S., Dietzen, D. J., Hastings, W. R., Lublin, D. M., & Kurzchalia, T. V. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00519-4 · Cited by 207
Expression of Caveolin-1 Is Required for the Transport of Caveolin-2 to the Plasma Membrane
Parolini, I., Sargiacomo, M., Galbiati, F., Rizzo, G., Grignani, F., Engelman, J. A., Okamoto, T., Ikezu, T., Scherer, P. E., Mora, R., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25718 · Cited by 207
Self-citationZundel, W., Swiersz, L. M., & Giaccia, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1507-1514.2000 · Cited by 184
Engelman, J. A., Zhang, X., Galbiati, F., Volonté, D., Sotgia, F., Pestell, R. G., Minetti, C., Scherer, P. E., Okamoto, T., & Lisanti, M. P. (1998) · The American Journal of Human Genetics · doi:10.1086/302172 · Cited by 182
Self-citationFra, A. M., Masserini, M., Palestini, P., Sonnino, S., & Simons, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)95228-o · Cited by 177
Mutational Analysis of the Properties of Caveolin-1
Song, K. S., Tang, Z., Li, S., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4398 · Cited by 163
Self-citationGalbiati, F., Volonté, D., Minetti, C., Chu, J. B., & Lisanti, M. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25632 · Cited by 158
Self-citationReduction of Caveolin 1 Gene Expression in Lung Carcinoma Cell Lines
Racine, C., Bélanger, M. M., Hirabayashi, H., Boucher, M., Chakir, J., & Couët, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0236 · Cited by 154
Engelman, J. A., Zhang, X. L., Galbiati, F., & Lisanti, M. P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00619-x · Cited by 145
Self-citationINK4d-Deficient Mice Are Fertile Despite Testicular Atrophy
Zindy, F., van Deursen, J., Grosveld, G. C., Sherr, C. J., & Roussel, M. F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.372-378.2000 · Cited by 144
LeCouter, J. E., Kablar, B., Hardy, W. R., Ying, C., Megeney, L. A., May, L. L., & Rudnicki, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7455 · Cited by 144
Mutational analysis of caveolin‐induced vesicle formation
Li, S. C., Galbiati, F., Volonté, D., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00945-4 · Cited by 130
Zhang, W., Razani, B., Altschuler, Y., Bouzahzah, B., Mostov, K. E., Pestell, R. G., & Lisanti, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909895199 · Cited by 122
Self-citationA new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells
Coats, S., Whyte, P., Fero, M. L., Lacy, S. E., Chung, G., Randel, E., Firpo, E. J., & Roberts, J. M. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80086-4 · Cited by 118
Molecular and Cellular Biology of Caveolae
Couët, J., Li, S. C., Okamoto, T., Scherer, P. E., & Lisanti, M. P. (1997) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(97)00001-7 · Cited by 117
Self-citationZenklusen, J. C., Thompson, J. C., Klein-Szanto, A. J., et al. (1995) · PubMed · Cited by 114
Caveolin Is an Inhibitor of Platelet-Derived Growth Factor Receptor Signaling
Yamamoto, M., Toya, Y., Jensen, R. A., & Ishikawa, Y. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4379 · Cited by 114
Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy
Razani, B., Schlegel, A., & Lisanti, M. P. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.12.2103 · Cited by 112
Self-citationInvolvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans
Scheel, J., Srinivasan, J., Honnert, U., HENSKE, A., & Kurzchalia, T. V. (1999) · Nature Cell Biology · doi:10.1038/10100 · Cited by 111
Wu, H., Liu, X., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2819 · Cited by 110
Song, K. S., Sargiacomo, M., Galbiati, F., Parenti, M. D., & Lisanti, M. P. (1997) · PubMed · Cited by 101
Self-citationHuang, H., Qian, C., Jenkins, R. B., & Smith, D. I. (1998) · Genes Chromosomes and Cancer · Cited by 76
WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras.
Ioffe, E., Liu, Y., Bhaumik, M., Poirier, F., Factor, S. M., & Stanley, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7357 · Cited by 68
Volonté, D., Galbiati, F., & Lisanti, M. P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00164-7 · Cited by 65
Self-citationLoss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas
Shridhar, V., Sun, Q. C., Miller, O. J., Kalemkerian, G. P., Petros, J. A., & Smith, D. I. (1997) · Oncogene · doi:10.1038/sj.onc.1201448 · Cited by 64
Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer
Koike, M., Takeuchi, S., Yokota, J., Park, S., Hatta, Y., Miller, C. W., Tsuruoka, N., & Koeffler, H. P. (1997) · Genes Chromosomes and Cancer · Cited by 56
Research works printed but not linked: 20
- Li, 1996, J. Biol. Chem., 271, 28647, 10.1074/jbc.271.45.28647 · doi:10.1074/jbc.271.45.28647
- Song, 1997, Cell. Mol. Biol., 43, 293
- Razani, 2000, Biochemistry, 39, 13916, 10.1021/bi001489b · doi:10.1021/bi001489b
- Park, 2001, Biochemistry, 40, 3354, 10.1021/bi002787b · doi:10.1021/bi002787b
- Bender, 2000, Cancer Res., 60, 5870
- Bagnoli, 2000, Oncogene, 19, 4754, 10.1038/sj.onc.1203839 · doi:10.1038/sj.onc.1203839
- Engelman, 1999, FEBS Lett., 448, 221, 10.1016/S0014-5793(99)00365-8 · doi:10.1016/s0014-5793(99)00365-8
- Suzuki, 1998, J. Biochem. (Tokyo), 124, 383, 10.1093/oxfordjournals.jbchem.a022123 · doi:10.1093/oxfordjournals.jbchem.a022123
- Jenkins, 1998, Cancer Res., 58, 759
- Zenklusen, 1994, Cancer Res., 54, 6370
- Zenklusen, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 12155, 10.1073/pnas.91.25.12155 · doi:10.1073/pnas.91.25.12155
- Huang, 1998, Genes Chromosomes Cancer, 21, 152, 10.1002/(SICI)1098-2264(199802)21:2<152::AID-GCC11>3.0.CO;2-T · doi:10.1002/(sici)1098-2264(199802)21:2<152::aid-gcc11>3.0.co;2-t
- Zenklusen, 1995, Cancer Res., 55, 1347
- Zenklusen, 1995, Oncogene, 11, 359
- Koike, 1997, Genes Chromosomes Cancer, 19, 1, 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3 · doi:10.1002/(sici)1098-2264(199705)19:1<1::aid-gcc1>3.0.co;2-3
- Achille, 1996, Cancer Res., 56, 3808
- Hayashi, 2001, Cancer Res., 61, 2361
- Das, 1999, J. Biol. Chem., 274, 18721, 10.1074/jbc.274.26.18721 · doi:10.1074/jbc.274.26.18721
- Gerdes, 1991, Am. J. Pathol., 138, 867
- Drab, 2001, Science
Cited by
Routes and mechanisms of extracellular vesicle uptake
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832
“CAV1 null mice show phenotypic changes in vasculature but are viable (106), suggesting that either CAV1 is not essential for full EV uptake or that the ability to internalize vesicles via CDE is not essential for viability.”
BackgroundSignaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2006) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,720
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Self-citationSystemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Caveolae: From Cell Biology to Animal Physiology
Razani, B., Woodman, S. E., & Lisanti, M. P. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.431 · Cited by 987
Self-citation
Metadata
- Authors
- Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H., Kneitz, B., Lagaud, G., Christ, G. J., Edelmann, W., & Lisanti, M. P.
- Venue
- Journal of Biological Chemistry
- Published
- 2001-10
- Volume
- 276
- Issue
- 41
- Pages
- 38121-38138
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1643087207
- Cited by
- 1,158
- References
- 96
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 6940 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.